{ "items": [ "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Dyson ZA. et al, (2025), Genome Medicine, 17

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Dold C. et al, (2025), Science Translational Medicine, 17

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Dysregulated immune proteins in plasma in the UK Biobank predict Multiple Myeloma 12 years before clinical diagnosis\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Fieggen J. et al, (2025), Blood Advances

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Benchmarking transformer-based models for medical record deidentification: A single centre, multi-specialty evaluation\n

\n \n \n

\n \n Preprint\n \n

\n \n\n \n \n \n

Kuo R. et al, (2025)

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Immune\u2013epithelial\u2013stromal networks define the cellular ecosystem of the small intestine in celiac disease\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

FitzPatrick MEB. et al, (2025), Nature Immunology

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Poolchanuan P. et al, (2025), Sci Rep, 15

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n An hourglass model for conceptualising stigma in infectious disease outbreaks\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Paterson A. et al, (2025), Scientific Reports, 15

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Zhang Y. et al, (2025), NPJ vaccines, 10

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Antibiotic use attributable to RSV infections during infancy-an international prospective birth cohort study.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Hak SF. et al, (2025), The Journal of antimicrobial chemotherapy

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Awake Prone Positioning in Adults With COVID-19\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Luo J. et al, (2025), JAMA Internal Medicine, 185, 572 - 572

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Capitalizing on a crisis: a computational analysis of all five million British firms during the Covid-19 pandemic\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Muggleton N. et al, (2025), Journal of Computational Social Science, 8

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries. \n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Ibarz-Pavon AB. et al, (2025), Vaccine, 56

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Early experiences of the End of Life Choice Act 2019 amongst assisted dying practitioners in Aotearoa New Zealand.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Dehkhoda A. et al, (2025), BMC palliative care, 24

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Establishment of a Lassa Fever Specimen Biobank in Nigeria.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Chi HF. et al, (2025), The American journal of tropical medicine and hygiene

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Ethical argument for establishing good manufacturing practice for phage therapy in the UK\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Suleman M. et al, (2025), Journal of Medical Ethics, 51

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Good bioethics and a good bioethicist: John McMillan's contributions to <i>JME</i>'s legacy.\n

\n \n \n

\n \n Other\n \n

\n \n\n \n \n \n

Fritz Z. et al, (2025), Journal of medical ethics

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Horizontal transfer of nuclear DNA in transmissible cancer.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Gori K. et al, (2025), Proceedings of the National Academy of Sciences of the United States of America, 122

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Lessons for future outbreaks from successful contact tracing systems in Asia\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Tan JXR. et al, (2025), The Lancet Regional Health - Western Pacific, 58

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Longitudinal Immunoprofiling of the CD8<sup>+</sup> T-Cell Response in SARS-CoV-2 mRNA Vaccinees and COVID-19 Patients.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Brunetti JE. et al, (2025), Vaccines, 13

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n The (Re)-emerging And ePidemic Infectious Diseases (RAPID) Stigma Scales: a cross-outbreak scale development and pyschometric validation study\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Paterson A. et al, (2025), The Lancet Infectious Diseases

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Pekar JE. et al, (2025), Cell

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n TSC2/mTORC1 integrates deoxynivalenol signals recognized by membrane receptors IR and EGFR to restrict intestinal stem cell function\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Dou C-X. et al, (2025), Journal of Hazardous Materials, 138769 - 138769

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Bayesian modelling of repeated cross-sectional epidemic prevalence survey data\n

\n \n \n

\n \n Preprint\n \n

\n \n\n \n \n \n

Steyn N. et al, (2025)

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

PALM007 Writing Group None. et al, (2025), N Engl J Med, 392, 1484 - 1496

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Feng S. et al, (2025), Lancet Glob Health

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Subpopulations in clinical samples ofM. tuberculosiscan give rise to rifampicin resistance and shed light on how resistance is acquired\n

\n \n \n

\n \n Preprint\n \n

\n \n\n \n \n \n

Brunner VM. and Fowler PW., (2025)

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n The value of large-scale programmes in human genomics\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Horn R. et al, (2025), European Journal of Human Genetics

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Application of large language models in medicine\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Liu F. et al, (2025), Nature Reviews Bioengineering

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Priorities for rapid and cost-effective vaccines to improve outbreak responses\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Gilbert SC., (2025), PLOS Biology, 23, e3003114 - e3003114

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Microtitre Plate Image Augmentation with Generative Adversarial Networks\n

\n \n \n

\n \n Conference paper\n \n

\n \n\n \n \n \n

Li R. et al, (2025), ICASSP 2025 - 2025 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), 1 - 5

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Ethical considerations in the routine identification of human remains in forensic mortuaries\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Reid KM. et al, (2025), Wellcome Open Research, 10, 171 - 171

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n A scoping review of large language models for generative tasks in mental health care.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Hua Y. et al, (2025), NPJ digital medicine, 8

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n A systems biology approach to define SARS-CoV-2 correlates of protection.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Brady C. et al, (2025), NPJ vaccines, 10

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Firth C. et al, (2025), Vaccine, 54, 127013 - 127013

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Author Correction: Call for a fairer approach to authorship in publishing biomedical research.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Cheah PY. and Parker M., (2025), Communications medicine, 5

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Call for a fairer approach to authorship in publishing biomedical research.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Cheah PY. and Parker M., (2025), Communications medicine, 5

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Corrigendum to \u201cClinical manifestations and outcomes of human mpox infection from 1970 to 2023: A systematic literature review\u201d [Clin. Infect. Pract. 24 (2024) 100397] (Clinical Infection in Practice (2024) 24, (S2590170224000578), (10.1016/j.clinpr.2024.100397))\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Abejegah C. et al, (2025), Clinical Infection in Practice, 26

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Creating different global health futures: mapping the health research ecosystem and taking decolonial action.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Tagoe N. et al, (2025), BMC health services research, 25

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Laidlaw SM. et al, (2025), Microbiology spectrum, 13

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Genetically distinct within-host subpopulations of hepatitis C virus persist after Direct-Acting Antiviral treatment failure\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Zhao L. et al, (2025), PLOS Pathogens, 21, e1012959 - e1012959

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n How COVID-19 affected academic publishing: a 3-year study of 17 million research papers.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Whitaker M. et al, (2025), International journal of epidemiology, 54

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Influence of context on engagement with COVID-19 testing: a scoping review of barriers and facilitators to testing for healthcare workers, care homes and schools in the UK\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Andersen-Waine B. et al, (2025), BMJ Open, 15, e089062 - e089062

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Key SARS-CoV-2 testing strategies implemented in the UK: rationale and impact.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Fowler T. et al, (2025), Journal of the Royal Society of Medicine, 118, 112 - 120

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Prepare: Improving End-of-Life Care Practice in Stroke Care: Insights from a National Survey and Semi-Structured Interviews.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Lightbody CE. et al, (2025), Healthcare (Basel, Switzerland), 13

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Quantifying prevalence and risk factors of HIV multiple infection in Uganda from population-based deep-sequence data.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Martin MA. et al, (2025), PLoS pathogens, 21

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Siegal EZ. et al, (2025), NPJ vaccines, 10

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies. \n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Laczi D. et al, (2025), European journal of medicinal chemistry, 291

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n The overlapping global distribution of dengue, chikungunya, Zika and yellow fever.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Lim A. et al, (2025), Nature communications, 16

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Trends in alcohol-specific deaths in England, 2001-22: an observational study. \n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Oldham M. et al, (2025), The Lancet. Public health

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Correction: Effect of early and later prone positioning on outcomes in invasively ventilated COVID-19 patients with acute respiratory distress syndrome: analysis of the prospective COVID-19 critical care consortium cohort study.\n

\n \n \n

\n \n Journal article\n \n

\n \n\n \n \n \n

Simpkin AJ. et al, (2025), Ann Intensive Care, 15

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n" ], "more": "\n\n \n \n Load More\n \n \n\n", "msg": "" }